Nucleix Ltd. Alternatives & Competitors
12 companies similar to Nucleix Ltd. — Developing cancer diagnostic panels based on epigenetic bio markers
AOA Dx
Transforming Women’s Health with Breakthrough Cancer Diagnostics and AI
Denver, United States
Cyted Health
Transforming access to digestive health for everyone, everywhere.
Cambridge, United Kingdom
MILAGEN, INC.
Advancing Health Care Through Diagnostics
inContAlert
Know your body. Own your life.
Bayreuth, Germany
Track all Nucleix Ltd. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Freenome
Outpacing cancer starts with early detection
Brisbane, United States
Tyra Biosciences
TYRA is focused on developing next-generation precision medicines that target large opport...
Carlsbad, United States
SAGA Diagnostics
Redefining the early detection of molecular residual disease (MRD).
Morrisville, United State...
Prokarium
LIVING CURES
London, United Kingdom
ACEA Therapeutics, Inc
Committed to improving the lives of patients with chronic and life-threatening diseases.
San Diego, United States
OncoSynergy
Physician-founded, patient-focused.
Stamford, United States
Avalyn Pharma
Revolutionizing respiratory care with every breath
Boston, United States
Asylia Therapeutics
Innovative therapies reshaping immune responses against autoimmune, cancer, and infectious...
About Nucleix Ltd.
Developing cancer diagnostic panels based on epigenetic bio markers
Development and Manufacturing of Non-Invasive Cancer Tests, Market Liquid Biopsy Assays, Research & Development in Cancer Detection, Collaboration with Leading Medical Institutions
High-Risk Individuals for Early Lung Cancer Detection, Patients with Primary and Recurrent Bladder Cancer, Healthcare Providers and Medical Centers
Cancer Diagnostics, Epigenetic Biomarkers, Liquid Biopsy, PCR-based Epigenetics, Methylation-based Identification, Non-invasive Testing, Bladder Cancer Detection, Lung Cancer Detection, Recurrent Cancer Monitoring, EpiCheck Platform, Medical Device CE-mark, FDA 510(k) Clearance, Urine-based Cancer Tests, Blood-based Cancer Tests, Molecular Diagnostic Tests
B2B, B2C, B2D
Product Sales, Licensing, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Nucleix Ltd. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Nucleix Ltd. on 22 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.